# Can We Find Cures Faster?

Page: https://stenobird.com/podcast/the-persistence-lab-7666293/can-we-find-cures-faster
Text version: https://stenobird.com/podcast/the-persistence-lab-7666293/can-we-find-cures-faster.md
Podcast: [The Persistence Lab](https://stenobird.com/podcast/the-persistence-lab-7666293)
Published: 2026-02-19T10:00:00+00:00
Episode link: https://www.abbvie.com/who-we-are/our-stories/the-persistence-lab-podcasts.html
Audio file: https://pscrb.fm/rss/p/audio-delivery.cohostpodcasting.com/audio/e6f8ee87-47be-4a8e-a2cd-6c7f13dff165/episodes/b2f81ae5-e9aa-4dd4-a2ca-19f7e361cc44/episode.mp3
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/the-persistence-lab-7666293/episodes/can-we-find-cures-faster
Duration seconds: 1355

## Resource

Our health and well-being impact every element of our lives. For patients with some of the most difficult-to-treat medical conditions, a cure is what they’re hoping for. How can we accelerate drug development to spur progress and turn bold ideas into real breakthroughs? We launch our journey into The Persistence Lab, a podcast sponsored by AbbVie, with a look at how the company is empowering scientists to boldly rethink what it means to cure disease and accelerate care for patients. Not intended for UK audiences. To learn more about AbbVie’s approach to scientific discovery, visit:  https://www.abbvie.com/science/our-people/community-of-science.html

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/the-persistence-lab-7666293/episodes/can-we-find-cures-faster/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/the-persistence-lab-7666293/can-we-find-cures-faster.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.